SpyGlass Pharma, Inc. Common Stock (SGP) is a publicly traded the market company. As of August 7, 2026, SGP trades at $24.51 with a market cap of $791.70M and a P/E ratio of -35.68. SGP moved -1.49% today. Year to date, SGP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $17.06 to $32.44. Analyst consensus is strong buy with an average price target of $47.00. Rallies surfaces SGP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SGP shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $24.51 |
| Market Cap | $791.70M |
| P/E Ratio | -35.68 |
| EPS | $-0.69 |
| Dividend Yield | 0.07% |
| 52-Week High | $32.44 |
| 52-Week Low | $17.06 |
| Volume | 32.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.82M |
| Gross Margin | 0.00% |
3 analysts cover SGP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.00.